The Pharmaceutical Journal
Vol 273 No 7306 p4
3 July 2004

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Related websites
Reclassification of medicines (more)

Voltarol Emulgel GSL application

Novartis Consumer Health has applied to have Voltarol Pain-Eze Emulgel (diclofenac diethylammonium 1.16 per cent) classified as a general sale list medicine (PDF 80K). The product is the same as Voltarol Emulgel, which is currently a pharmacy medicine and which will remain available.